Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for AI-enabled robotics, imaging and other features.
The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict breast cancer risk over five years.
Supply chain management is key for patient safety in clinical trials, with failures leading to medication errors and adverse reactions. Learn how to optimize your trial supply chain and enhance safety in this playbook.
